| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/07/2005 | WO2005030801A1 A novel conotoxin modulating sodium channels |
| 04/07/2005 | WO2005030798A2 TNFαCONVERTING ENZYME INHIBITORY AGENTS AND STIMULATORY AGENTS- |
| 04/07/2005 | WO2005030797A2 Melanocortin receptor agonists |
| 04/07/2005 | WO2005030261A1 Oncolytic adenoviral vectors encoding gm-csf |
| 04/07/2005 | WO2005030250A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | WO2005030241A2 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 04/07/2005 | WO2005030240A2 Vege-cor vege-d materials and methods for stimulation of neural stem cells |
| 04/07/2005 | WO2005030238A1 Peptides having, for example, an antiangiogenic activity and applications thereof in therapeutics |
| 04/07/2005 | WO2005030145A2 Composition and pharmacology of novel alpha-6-containing nicotinic acetylcholine receptors |
| 04/07/2005 | WO2005030139A2 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | WO2005030136A2 Tumor vaccine |
| 04/07/2005 | WO2005030119A2 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
| 04/07/2005 | WO2005030032A2 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes |
| 04/07/2005 | WO2005016960A3 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 04/07/2005 | WO2005012535A3 Method for producing life attenuated viruses and use of viral particles thus produced. |
| 04/07/2005 | WO2005012351A8 Novel functions for decay accelerating factor (daf) in inflammation |
| 04/07/2005 | WO2005012345A8 Perfusion method for producing erythropoietin |
| 04/07/2005 | WO2005010157A3 Use of pleiotrophin in the diagnosis, treatment and prevention of disease |
| 04/07/2005 | WO2005005625A3 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor |
| 04/07/2005 | WO2005000893A3 Pharmaceutical composition comprising cyclic somatostin analogues |
| 04/07/2005 | WO2004111608A3 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 04/07/2005 | WO2004108760A3 Improved secretion of neublastin |
| 04/07/2005 | WO2004103067A3 A transgenic animal model for cancer and stem cells |
| 04/07/2005 | WO2004096976A3 Spex compositions and methods of use |
| 04/07/2005 | WO2004096842A3 Sars virus nucleotide and amino acid sequences and uses thereof |
| 04/07/2005 | WO2004094600A3 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 04/07/2005 | WO2004092207A3 Respiratory syncytial virus (rsv) peptides |
| 04/07/2005 | WO2004074446A3 Parkin interacting polypeptides and methods of use |
| 04/07/2005 | WO2004074313A3 Methods for prediction of amyloid fibril formation and identification of peptides useful as therapeutic and diagnostic agents |
| 04/07/2005 | WO2004066953A3 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 04/07/2005 | WO2004063324A3 Canine gene microarrays |
| 04/07/2005 | WO2004053079A3 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 04/07/2005 | WO2004039988A9 Ppr peptide sequences capable of restoring male fertility of plants bearing a male sterility-inducing cytoplasm |
| 04/07/2005 | WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 04/07/2005 | WO2004007695A3 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 04/07/2005 | WO2003098186A3 Bioengineering cotton fiber properties |
| 04/07/2005 | WO2003094860A3 Use of homo sapiens chromosome 1 open reading frame 28 (c1orf28) in the diagnosis of hyperparathyroidism-jaw tumor syndrome |
| 04/07/2005 | WO2003093452A3 Variants of nedd4l associated with hypertension and viral budding |
| 04/07/2005 | WO2003093434A3 Nanoarchaeum nucleic acid molecule |
| 04/07/2005 | WO2003093416A3 Protective antigens for the control of ixodes species infestations |
| 04/07/2005 | WO2003093293A3 Peptide antagonists of tgf-beta family members and therapeutic uses thereof |
| 04/07/2005 | WO2003092593A3 Tumor suppressor gene polypeptides |
| 04/07/2005 | WO2003070915A3 Mutated constitutively active nuclear orphan receptor |
| 04/07/2005 | WO2003063688A3 Protein modification and maintenance molecules |
| 04/07/2005 | WO2003062395A3 Predictor sets for tyrosine kinase pathways |
| 04/07/2005 | WO2003057711A3 Isolated cytokine receptor licr-2 |
| 04/07/2005 | WO2003030612A3 Methods for modulating activity of the fxr nuclear receptor |
| 04/07/2005 | WO2002066615A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 04/07/2005 | WO2002045659A3 Novel therapeutics for heart failure and aging |
| 04/07/2005 | US20050076412 Enhancing freeze, drought and/or salinity tolerance of agricultural crops; transforming with recombinant polynucleotide encoding C repeat/DRE binding factor related polypeptide and expressing into cells |
| 04/07/2005 | US20050076410 Expression vector comlprising nucleotide sequences coding nitric acid reductase (NOR) for use in transformation and generation of plants with enhance food ripening |
| 04/07/2005 | US20050076408 Expression vector comprising nucleotide sequences coding ripening inhibitor protein (RIN) for use as tool in transformation and propagation of plants w ith enhanced ripening |
| 04/07/2005 | US20050076407 Plant defensin polynucleotides and methods of use thereof |
| 04/07/2005 | US20050076406 Plant-derived resistance gene |
| 04/07/2005 | US20050076404 Cell cycle polynucleotides, polypeptides and uses thereof |
| 04/07/2005 | US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics |
| 04/07/2005 | US20050075511 Prevention of human and/or animal viral, bacterial, fungal or parasitic infections; plant fungicides, bactericides and/or herbicides; reduced side effects; environmentally friendly; such as ((n-formyl-n-hydroxyamino)-methoxy)-methyl phosphonic acid disodium salt |
| 04/07/2005 | US20050075496 Plasmodium falciparum antigens and their vaccine and diagnostic applications |
| 04/07/2005 | US20050075495 Probes for chondrogenesis |
| 04/07/2005 | US20050075494 Nucleotide sequences coding orphan receptor for use as tools in diagnosis , prevention and treatment of nervous system and psychotic disorders |
| 04/07/2005 | US20050075493 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 04/07/2005 | US20050075486 A monoclonal antibody produced by hybridoma deposited as 96-109FE8 IH11 which agglutinates bacteria bearing CS4-CFA/I family of proteins and binds exclusively and specifically to amino acid sequence serine-alanine-valine-alanine-leucine-threonine-tyrosine-serine |
| 04/07/2005 | US20050075485 Neisseria meningitidis antigen |
| 04/07/2005 | US20050075484 Construction and use of synthetic constructs encoding syndecan |
| 04/07/2005 | US20050075483 Vancomycin derivatives linked with disaccharide sugar, obtained by deprotecting a protected glycopeptide, by sulfonation, replacement; preparing a glycopeptide by glycosylation of an aglycone derived from glycopeptide antibiotic |
| 04/07/2005 | US20050075481 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 04/07/2005 | US20050075480 Urotensin-II agonists and antagonists |
| 04/07/2005 | US20050075303 Synthetic human papilloma virus genes |
| 04/07/2005 | US20050075291 mixture of anticoagulants and a protein C or activated protein C polypeptide comprising a modified gamma -carboxyglutamic acid (GLA) domain to enhance membrane binding receptivity, used for modulation of coagulation in mammals |
| 04/07/2005 | US20050075290 For drug screening pituitary adenylate cyclase activating peptide (PACAP)/vasoactive intestinal peptide (VIP) receptor antagonists; oral/nasal/intravenous/arterial administration |
| 04/07/2005 | US20050075286 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 04/07/2005 | US20050075284 peptide analogues or conjugates of vasoactive intestinal peptide(VIP), used for vaginal relaxation and/or for modulation of sperm motility |
| 04/07/2005 | US20050075283 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/07/2005 | US20050075278 Compositions of sunflower trypsin inhibitors |
| 04/07/2005 | US20050075277 Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
| 04/07/2005 | US20050075102 Personal-call and feature control system and method for controlling telephones, providing extended features for such telephones and routing of media-rich calls |
| 04/07/2005 | US20050074895 analysis of protein expression by the reaction of proteins with alkyl-substituted vinyl pyridines as thiol alkylating agents; mass difference is considerably greater than that achieved by isotope tagging |
| 04/07/2005 | US20050074887 Adenoviral VA1 Pol III promoter system for RNAi expression |
| 04/07/2005 | US20050074886 Recombinant vector derived from adeno-associated virus for gene therapy |
| 04/07/2005 | US20050074885 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/07/2005 | US20050074882 Using immunoglobulin specific to human leukocyte antigen receptor to modify mitochondrial metabolism and kill tumor cells; immunotherapy; antitumor agents |
| 04/07/2005 | US20050074881 Chronic pathogen-expressing cell lines |
| 04/07/2005 | US20050074864 Expression vector comprising nucleotide sequences coding carybdea blood lysis protein for use as tool in treatment and prevetion of platelet agglutination disorders; pesticides |
| 04/07/2005 | US20050074862 Polynucleotides encoding defense responde proteins |
| 04/07/2005 | US20050074856 Methods and compositions for increasing protein yield from a cell culture |
| 04/07/2005 | US20050074855 High affinity fusion proteins and therapeutic and diagnostic methods for use |
| 04/07/2005 | US20050074854 Glycosylated specificity exchangers |
| 04/07/2005 | US20050074853 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 04/07/2005 | US20050074851 Vesicle associated proteins |
| 04/07/2005 | US20050074850 Drug screening; recombinant cells; for inhibiting calcineurin activity and interleukin production; antiproliferative agents |
| 04/07/2005 | US20050074849 Peptides |
| 04/07/2005 | US20050074848 Major histocompatibility complex fusion comprising human cartilage oligomeric matrix protein (COMP) for use in prevention and treatment of cancer, infection, autoimmune and transplant rejection |
| 04/07/2005 | US20050074847 Human prostaglandin EP1 receptor variants and methods of using same |
| 04/07/2005 | US20050074845 Use of Saccharomyces cerevisiae Erg4 mutants for expressing mammalian glucose transporters |
| 04/07/2005 | US20050074842 Membrane protein for use as tools in generation of vaccine; medical diagnosic and drug screening tools |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074840 Folded recombinant tumor necrosis polypeptide comprising substituted proline for use as tool in treatment of inflammatory disorders |
| 04/07/2005 | US20050074839 Novel survivin interacting protein tpr1 |
| 04/07/2005 | US20050074838 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 04/07/2005 | US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same |